Category:
Chiral Intermediates
CAS NO:
357336-20-0
Standard:
In-house Standards,
| Name | Brivaracetam | |
| Synonyms | (alphaS,4R)-alpha-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide; UCB-34714 | |
![]() |
||
| Molecular Structure | ![]() |
|
| Molecular Formula | C11H20N2O2 | |
| Molecular Weight | 212.29 | |
| CAS Registry Number | 357336-20-0 | |
Brivaracetam is a high-potency antiepileptic drug (AED) derived from levetiracetam. Its core synthesis involves advanced organic coupling and purification processes to ensure pharmaceutical grade purity. The compound features the molecular formula C12H14N2O2 with CAS number 79683-01-5.
Strictly controlled storage at 25°C or below in dry, sealed containers. Clinical use requires monitoring for CNS side effects like dizziness and somnolence. Regulatory compliance is mandatory for all industrial handling and distribution channels.